NTRANatera Inc
NTRA
Natera Inc2,440
Mkt Cap
$26.69BVolume
2.24M52W High
$256.3652W Low
$131.81PE Ratio
-113.54NTRA Fundamentals
Price
$186.36Prev Close
$196.91Open
$197.6150D MA
$201.10Beta
1.30Avg. Volume
1.31MEPS (Annual)
-$1.52P/B
14.99Rev/Employee
$375,588.44$30,459.65
Signatera CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC)
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved Signatera CDx as a companion diagnostic (CDx) for use with adjuvant atezolizumab (Tecentriq) immunotherapy in MIBC. This is the first...
Business Wire·1d ago
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates
Natera (NTRA) delivered earnings and revenue surprises of -5.26% and +13.26%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Natera (NTRA) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·9d ago
Natera Reports First Quarter 2026 Financial Results
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the first quarter ended March 31, 2026. Recent Financial Highlights...
Business Wire·9d ago
EXEL Q1 Earnings Top Estimates, Colorectal Cancer Drug in Focus
EXEL beats Q1 EPS estimates on lower costs and buybacks but misses on revenues; Cabometyx sales lag estimates as pipeline progress and new buybacks stay in focus.
Zacks·10d ago
Insider Selling: Natera (NASDAQ:NTRA) CFO Sells 313 Shares of Stock
Natera, Inc. (NASDAQ:NTRA - Get Free Report) CFO Michael Burkes Brophy sold 313 shares of the firm's stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $206.16, for a total transaction of $64,528.08. Following the completion of the sale, the chief financial...
MarketBeat·11d ago
Natera (NASDAQ:NTRA) Insider Sells $59,992.56 in Stock
Natera, Inc. (NASDAQ:NTRA - Get Free Report) insider John Fesko sold 291 shares of Natera stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $206.16, for a total transaction of $59,992.56. Following the completion of the transaction, the insider owned...
MarketBeat·11d ago
Insider Selling: Natera (NASDAQ:NTRA) Insider Sells 3,405 Shares of Stock
Natera, Inc. (NASDAQ:NTRA - Get Free Report) insider Solomon Moshkevich sold 3,405 shares of the business's stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $203.69, for a total value of $693,564.45. Following the completion of the sale, the...
MarketBeat·11d ago
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 902 Shares of Stock
Natera, Inc. (NASDAQ:NTRA - Get Free Report) CEO Steven Leonard Chapman sold 902 shares of the business's stock in a transaction on Friday, May 1st. The stock was sold at an average price of $206.16, for a total transaction of $185,956.32. Following the completion of the sale, the chief executive...
MarketBeat·11d ago
Natera (NASDAQ:NTRA) CFO Sells $101,456.18 in Stock
Natera, Inc. (NASDAQ:NTRA - Get Free Report) CFO Michael Burkes Brophy sold 482 shares of Natera stock in a transaction that occurred on Monday, May 4th. The shares were sold at an average price of $210.49, for a total transaction of $101,456.18. Following the sale, the chief financial officer...
MarketBeat·11d ago
<
1
2
...
>